CLINICAL_TRIALS
trial_result
· 2026-03-16
Clinical Trial Update: Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer [Phase 2]
Summary
Phase 2 results are reported for letrozole in post-menopausal patients with operable hormone-sensitive breast cancer. Results were posted on 2026-03-16.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Texas Southwestern Medical Center | Conditions: Breast Cancer Female | Phase 2 | Status: COMPLETED | Results posted: 2026-03-16